Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

By B. Leyland-Jones, V. Semiglazov, M. Pawlicki, T. Pieńkowski, S. Tjulandin, G. Manikhas, A. Makhson, A. Roth, D. Dodwell, J. Baselga and 5 more. Journal of Clinical Oncology, 2005

686 citations recorded by the source corpus.

Subfields: Hematology, Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/d982314778019d597364db67701aba7f70787a2b

Citations in the corpus

• Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. (2008, neutral): “35) EPO-CAN-15,11 2004 21/53 (40) 10/53 (19) 0.”